Enovix (ENVX) vs Ultralife (ULBI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Ultralife (ULBI) has outperformed Enovix (ENVX) over the past year, gaining 197.3% versus a loss of 84.3%. Over five years, ULBI leads with a +181.7% price change compared with -96.6% for ENVX. Ultralife is the larger company by market cap ($259.6 million vs $248.6 million), about 1.0 times the size, while Enovix is growing revenue faster (+37.9% vs +16.2%).
Ultralife converts more of its revenue into profit, with a net margin of -3.1% versus -492.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENVX | ULBI |
|---|---|---|
| Share price | $1.17 | $15.58 |
| Market cap | $248.60M | $259.63M |
| 1-day change | -9.30% | -0.70% |
| YTD return | -83.99% | +172.38% |
| 1-year return | -84.34% | +197.33% |
| 5-year return | -96.64% | +181.74% |
| Forward P/E | — | 17.31 |
| EPS (TTM) | $-0.72 | $-0.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $31.82M | $191.16M |
| Revenue growth (YoY) | +37.91% | +16.24% |
| Net income (latest FY) | $-156.74M | $-5.90M |
| Gross margin | 19.19% | 24.07% |
| Operating margin | -557.03% | -3.09% |
| Net margin | -492.57% | -3.09% |
| 52-week high | $9.19 | $15.83 |
| 52-week low | $1.13 | $5.00 |
| Distance from 52-week high | -87.27% | -1.58% |
| Analyst consensus | buy | — |
| Avg. price target upside | +156.41% | — |
| Average volume | 8.59M | 129.78K |
| Shares outstanding | 212.48M | 16.66M |
| Employees | 664 | 678 |
| Sector | Miscellaneous | Miscellaneous |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ULBI has outperformed ENVX by 281.7 percentage points over the past year.
- Ultralife is more profitable, keeping -3.1 cents of every revenue dollar as net income versus -492.6 cents for Enovix.
- Enovix grew revenue faster in its latest fiscal year (+37.91% vs +16.24%).
About Enovix
ENVX stock →Enovix Corporation designs, develops, and manufactures lithium-ion battery cells in the United States and internationally. It serves wearables and IoT, smartphone, computing, electrical vehicles, and original equipment manufacturers.
Miscellaneous · Industrial Machinery/Components · 664 employees
About Ultralife
ULBI stock →Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems.
Miscellaneous · Industrial Machinery/Components · 678 employees
ENVX vs ULBI FAQ
Which is bigger, Enovix or Ultralife?
Ultralife (ULBI) is larger, with a market capitalization of $259.63M compared with $248.60M for Enovix (ENVX).
Which stock has performed better over the past year, ENVX or ULBI?
ULBI returned +197.33% over the past 12 months, compared with -84.34% for ENVX (price return, excluding dividends). Past performance does not predict future results.
Are Enovix and Ultralife in the same industry?
Yes. Both are classified in the Industrial Machinery/Components industry within the Miscellaneous sector.